AJ

Arushi Jain

Active Director Director DIN 08012943
DIN 08012943 First appointment Sep 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Sep 2012
Shareholding value •••• Premium profile

About Arushi Jain

Data last updated:

Arushi Jain is a Director at Hygosap Pharma Private Limited (since 2021), Designated Partner at Dhanwantri Vedaresearch Llp (since 2024) and Director at American Remedies Lifesciences Limited (since 2020). The companies operate in Pharma, Business Services and E-Commerce. The 2 current companies with reported revenue have a combined latest revenue of ₹3.5 Lakh; the largest is Hygosap Pharma Private Limited at ₹3.5 Lakh (FY 2026). Earlier, Arushi Jain was a Director at Medibox Pharma Private Limited (2017–2025) and Director at Aleafiaa Pharmaceuticals Private Limited (2018–2021) and 2 more.

DIN 08012943
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2012
Oldest Company Age 6 yrs
Largest company Hygosap Pharma Private Limited · ₹3.5 Lakh (FY 2026)
Combined revenue ₹3.5 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hygosap Pharma Private Limited U24290DL2021PTC376044
Director22 Jan 20212021₹3.5 Lakh (FY 2026)Active
Designated Partner30 Mar 20242020₹3,085 (FY 2026)Active
Director13 Oct 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medibox Pharma Private Limited U72900DL2016PTC399490
Director08 Dec 20172016₹18.01 Cr (FY 2026)Active
Director23 Nov 20182017₹17 Lakh (FY 2024)Active
Partner30 Sep 20122010Active
German Remedies Lifesciences Limited U24304DL2020PLC371884
Director20 Oct 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dhanwantri Vedaresearch Llp
Hygosap Pharma Private Limited
American Remedies Lifesciences Limited
German Remedies Lifesciences Limited
Premium access

Shareholding and investment profile for Arushi Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arushi Jain

Arushi Jain currently holds 3 directorships: Hygosap Pharma Private Limited (Director, since 22 Jan 2021, revenue ₹3.5 Lakh (FY 2026)); Dhanwantri Vedaresearch Llp (Designated Partner, since 30 Mar 2024, revenue ₹3,085 (FY 2026)); American Remedies Lifesciences Limited (Director, since 13 Oct 2020).

Arushi Jain was first appointed on 30 Sep 2012 as Partner at Upadhrish Reserchem Llp. The most recent appointment on record is 30 Mar 2024 at Dhanwantri Vedaresearch Llp.

The 2 current companies of Arushi Jain that report revenue have a combined latest revenue of ₹3.5 Lakh: Hygosap Pharma Private Limited ₹3.5 Lakh (FY 2026); Dhanwantri Vedaresearch Llp ₹3,085 (FY 2026).

Arushi Jain held 4 earlier board appointments: Medibox Pharma Private Limited (Director, 08 Dec 2017 to 14 Nov 2025); Aleafiaa Pharmaceuticals Private Limited (Director, 23 Nov 2018 to 30 Mar 2021); Upadhrish Reserchem Llp (Partner, 30 Sep 2012 to 01 Apr 2019); German Remedies Lifesciences Limited (Director, from 20 Oct 2020).

The current boards of Arushi Jain's companies include Shivangi Jain (Hygosap Pharma Private Limited), Umang Jain (Hygosap Pharma Private Limited), Kanishk Jain (Dhanwantri Vedaresearch Llp), Man Mohan Sharma (Dhanwantri Vedaresearch Llp), Rashmi Gupta (American Remedies Lifesciences Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available